Upstate Active Clinical Trials
Study Title:
A Phase 3, Multi-center, Open-Label, Randomized, Comparator-Controlled Trial of the Safety and Efficacy of Dalbavancin versus Active Comparator in Pediatric Subjects with Acute Bacterial Skin and Skin Structure InfectionsWhat is the purpose of the study? (in Layman's terms, please describe the study)
The purpose of this research study is to determine how well dalbavancin works compared to standard antibiotic treatment (comparator) for ABSSSI in children.Upstate Institutional Review Board (IRB) Number:
934788Study/Protocol ID:
DUR001-306Study Phase:
Phase IIIPatient Age Group:
ChildrenPrincipal Investigator:
Leonard B WeinerWho can I contact for more information?
Name: Lori J Ferguson
Phone: 315-464-6331
Email: [email protected]